Grant: Canada Postdoctoral Research Award (CPRA) program
Direct Payment
$140,000.00
Combining multi-omics data integration and machine learning to uncover cancer-specific splicing variants
FY 2025-26
Summary
Despite major advances in diagnoses and treatments over the last decades, cancer still claims the lives of about one in four Canadians. One reason behind this high mortality rate is that generic therapies are often broadly applied across patients suffering from the same type of cancer. While this approach may appear reasonable, it overlooks the fact that every tumor is unique, much like every individual is different from one another due to different genetics and environment in which they evolve. To bring personalized medicine one step closer to patient, new research is needed to develop patient-specific therapies against cancer. One way to tackle this challenge is through the use of genome sequencing, a method that allows to identify all the mutations that we harbor in our DNA. Using an integrative bioinformatics approach, we will analyze mutations across a vast panel of more than 21,000 cancer samples in order to determine how their progression is regulated. Building on these findings, we will test an innovative technique called antisense oligonucleotides in an attempt to reverse cancer cell progression to normal. Taken together, this project aims to reveal previously overlooked cancer targets through in-depth analyses of large cohorts of patient datasets, ultimately providing more tailored treatment options to cancer patients.
Department
Program
Canada Postdoctoral Research Award (CPRA) program
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
536729
Name
Fafard-Couture Étienne
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
Combining multi-omics data integration and machine learning to uncover cancer-specific splicing variants
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Bioinformatics; Cancer; Dna Variants; Gene Regulation; Genomics; Machine Learning; Rna Sequencing; Splicing Regulation; Transcriptomics; Whole-Genome Sequencing
Abstract
Despite major advances in diagnoses and treatments over the last decades, cancer still claims the lives of about one in four Canadians. One reason behind this high mortality rate is that generic therapies are often broadly applied across patients suffering from the same type of cancer. While this approach may appear reasonable, it overlooks the fact that every tumor is unique, much like every individual is different from one another due to different genetics and environment in which they evolve. To bring personalized medicine one step closer to patient, new research is needed to develop patient-specific therapies against cancer. One way to tackle this challenge is through the use of genome sequencing, a method that allows to identify all the mutations that we harbor in our DNA. Using an integrative bioinformatics approach, we will analyze mutations across a vast panel of more than 21,000 cancer samples in order to determine how their progression is regulated. Building on these findings, we will test an innovative technique called antisense oligonucleotides in an attempt to reverse cancer cell progression to normal. Taken together, this project aims to reveal previously overlooked cancer targets through in-depth analyses of large cohorts of patient datasets, ultimately providing more tailored treatment options to cancer patients.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Fafard-Couture, Étienne
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~